Galmed Pharmaceuticals (EOCN) Consolidated Net Income (2013 - 2026)
Galmed Pharmaceuticals (EOCN) reported Consolidated Net Income of $2.67 million for Q2 2026, up 6.8% from $2.5 million a year earlier and up 34.2% from the prior quarter.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Consolidated Net Income (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Galmed Pharmaceuticals' Consolidated Net Income came in at $8.25 million, up 419.0% year-over-year; for FY2025, it came in at $10.2 million, up 36.3% from FY2024.
- Consolidated Net Income has a five-year compound annual growth rate of -18.6% (FY2020 to FY2025).
- By year, Consolidated Net Income came in at $7.48 million in FY2024 (+13.0%), $6.62 million in FY2023 (-64.1%), $18.44 million in FY2022 (-44.0%) and $32.91 million in FY2021 (+15.3%).
- The Q2 2026 figure ranks as the highest quarterly Consolidated Net Income since Q3 2022.
- Year over year, Consolidated Net Income gained in four of the last five quarters, with growth averaging 46.2%.
- The high point for year-over-year Consolidated Net Income in five years was Q2 2025 (growth of 127.6%); the low point was Q1 2023 (a decline of 73.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Galmed Pharmaceuticals | 2.06 Mn | -38.64 Mn | - | 2.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.67 Mn |
| Mar 31, 2026 | 1.99 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 1.09 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Sep 30, 2024 | 1.82 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 1.61 Mn |
| Mar 31, 2023 | 1.73 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Sep 30, 2022 | 5.24 Mn |
| Jun 30, 2022 | 4.10 Mn |
| Mar 31, 2022 | 6.59 Mn |
| Dec 31, 2021 | 7.55 Mn |
| Sep 30, 2021 | 7.90 Mn |
| Jun 30, 2021 | 8.43 Mn |
| Mar 31, 2021 | 9.04 Mn |
API Access
Galmed Pharmaceuticals Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();